Shanzebio is a specialized platform company dedicated to the introduction and commercialization of innovative pharmaceutical products from around the world.
Our vision is to become a leader in the biopharmaceutical industry, focusing on critical care, anti-infectives, and respiratory diseases; our mission is to safeguard human life and health through innovation and speed.
Invested by HSG, we are committed to providing sustainable medical solutions for patients worldwide through operating core product while introducing innovative pipelines.
In the future, we will remain rooted in China while leveraging our proven commercialization model and global operational capabilities to bring cutting-edge innovative products to patients worldwide, further advancing human health.
October 22, 2025
Shanzebio was officially established
February 02, 2026
Operations officially commenced